O-2113
From Wikipedia, the free encyclopedia
 | |
|---|---|
| Systematic (IUPAC) name | |
| (6aR,10aR)-3-(1-ethanesulfonylamino-5-methyl-hexan-5-yl)-6a,7,10,10a-tetrahydro-6,6,9-trimethyl-6H-dibenzo[b,d]pyran | |
| Clinical data | |
| Legal status | ? |
| Identifiers | |
| ATC code | ? |
| PubChem | CID 11775273 |
| ChemSpider | 26333261 |
| Chemical data | |
| Formula | C25H39NO4S |
| Mol. mass | 449.645 g/mol |
| SMILES
| |
| |
 (what is this?) | |
O-2113 is a drug that is a classical cannabinoid derivative, which acts as a potent agonist for cannabinoid receptors, producing sedation, hypothermia and analgesia in animal studies.[1]
See also
References
- ↑ Martin, et al. SULFONAMIDE CANNABINOID AGONISTS AND ANTAGONISTS. US Patent 7279500, Oct 9 2007
This article is issued from Wikipedia. The text is available under the Creative Commons Attribution/Share Alike; additional terms may apply for the media files.